David Grossman

Charles Rhyee

Ashok Kumar

Charles Reid

Theodore O'Neill

- DarioHealth Corp. announced a **20-for-1 reverse stock split** of its common stock.  **[1533998_0001104659-25-082513_tm2524185d1_ex3-1.htm:0]** **[1533998_0001104659-25-082513_tm2524185d1_ex99-1.htm:0]** **[1533998_0001104659-25-082513_tm2524185d1_8k.htm:1]** 
- The reverse stock split will become effective at 12:01 a.m. Eastern Time on **August 28, 2025**, with trading on a post-split basis commencing at market open on the same day under the existing symbol "DRIO" and a new CUSIP Number, **23725P 308**.  **[1533998_0001104659-25-082513_tm2524185d1_ex3-1.htm:0]** **[1533998_0001104659-25-082513_tm2524185d1_ex99-1.htm:0]** **[1533998_0001104659-25-082513_tm2524185d1_8k.htm:1]** 
- This action will reduce the outstanding common shares from **47,996,572** to approximately **2,399,829**, with any fractional shares rounded up to the nearest whole share.  **[1533998_0001104659-25-082513_tm2524185d1_ex99-1.htm:0]** **[1533998_0001104659-25-082513_tm2524185d1_8k.htm:1]** 
- The reverse stock split was approved by the Company's board of directors under authority granted by stockholders at the 2025 Annual Meeting held on July 23, 2025.  **[1533998_0001104659-25-082513_tm2524185d1_ex99-1.htm:0]** **[1533998_0001104659-25-082513_tm2524185d1_8k.htm:1]**

DarioHealth (DRIO)